Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Dopamine D2 and D3 Receptor Occupancy and Clinical Response in Older Patients With Schizophrenia

NCT00825045 is registered in ClinicalTrials.gov with Centre for Addiction and Mental Health as lead sponsor.

NCT NCT00825045
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00825045 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Dopamine D2 and D3 Receptor Occupancy and Clinical Response in Older Patients With Schizophrenia
Lead sponsor
Centre for Addiction and Mental Health
Phase
Not applicable
Overall status
Unknown status
Start date
December 31, 2008
Completion date
December 31, 2020
Enrollment
14 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

schizoaffective disorder, schizophrenia, schizophreniform disorder